[Chemotherapy of urinary tract infections in children and standards for evaluating its efficacy--with special reference to the therapeutic results of cephalexin suspensions].
D000284:Administration, Oral; D000293:Adolescent; D002506:Cephalexin / Q000008:administration & dosage* / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004352:Drug Resistance, Microbial; D004926:Escherichia coli / Q000187:drug effects; D004927:Escherichia coli Infections / Q000188:drug therapy; D005260:Female; D006801:Humans; D007223:Infant; D007711:Klebsiella pneumoniae / Q000187:drug effects; D008297:Male; D011512:Proteus Infections / Q000188:drug therapy; D011513:Proteus mirabilis / Q000187:drug effects; D011514:Proteus vulgaris / Q000187:drug effects; D011704:Pyelonephritis / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects; D013290:Streptococcal Infections / Q000188:drug therapy; D013291:Streptococcus / Q000187:drug effects; D013535:Suspensions; D001745:Urinary Bladder Diseases / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy*
D013535:Suspensions; D002506:Cephalexin